| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 05/04/2006 | US20060094737 Novel uracil derivatives and medicinal use thereof |
| 05/04/2006 | US20060094725 N-heterocyclic derivatives as NOS inhibitors |
| 05/04/2006 | US20060094720 NK1 antagonists |
| 05/04/2006 | US20060094691 Inclusion complexes of rosiglitazone |
| 05/04/2006 | US20060094688 Histamine release inhibitor |
| 05/04/2006 | US20060094686 Use of corrinoids for application in skin diseases |
| 05/04/2006 | US20060094647 Treatment of inflammatory bowel disease using growth factors |
| 05/04/2006 | US20060094043 Genes displaying enhanced expression during cellular senescence and terminal cell differentiation and uses thereof |
| 05/04/2006 | US20060093690 Novel therapeutic use of polypodium extracts |
| 05/04/2006 | US20060093636 Allantoin-containing skin cream |
| 05/04/2006 | US20060093611 from mammalian chondrocyte progenitor cells expressing mechanosensitive TWIK-related potassium (TREK) ion channels; biocompatability, in vitro |
| 05/04/2006 | US20060093598 Stabilized liquid polypeptide-containing pharmaceutical compositions |
| 05/04/2006 | US20060093576 Stabilized liquid polypeptide-containing pharmaceutical compositions |
| 05/04/2006 | US20060093574 Methods for epitope-specific and cytokine/anticytokine combination immunotherapies for modulation of pathogenic immune responses in immune mediated diseases |
| 05/04/2006 | US20060093567 Method of inhibiting hair growth |
| 05/04/2006 | DE19916208B4 Sonnenschutzmittel Sunscreens |
| 05/04/2006 | DE10320602B4 Verfahren zur Identifizierung einer möglichen Modifikation von mindestens einem biologischen Parameter unter Verwendung von jungen und alten lebenden Zellen A method for identifying a possible modification of at least one biological parameters using young and old living cells |
| 05/04/2006 | DE102004052987A1 Composition, useful for treatment of e.g. inflammatory and obstructive respiratory complaint, sinus rhythm in heart in atrioventricular block and circulatory shock, comprises 6-hydroxy-4H-benzo1,4oxazin-3-one derivatives and other actives |
| 05/04/2006 | CA2585293A1 Lip enhancement compositions |
| 05/04/2006 | CA2583677A1 Tnf-like weak inducer of apoptosis (tweak) receptor binding domain |
| 05/04/2006 | CA2583446A1 Method of using adapalene in acne maintenance therapy |
| 05/03/2006 | EP1652847A1 Quinoline and quinazoline derivatives for the treatment of tumors |
| 05/03/2006 | EP1652841A1 Novel phenantridine analogues and their use as inhibitors of hyperproliferation of T cells and/or keratinocytes |
| 05/03/2006 | EP1651638A1 Pyridyl piperazinyl ureas |
| 05/03/2006 | EP1651636A1 Substituted heterocyclic diarylamine analogues |
| 05/03/2006 | EP1651342A2 Combinatorial synthesis on support |
| 05/03/2006 | EP1651254A1 Use of alpha 1-antichymotrypsin polypeptides, or nucleic acids encoding them, in combination with alpha 1-antitrypsin polypeptides, or nucleic acids encoding them, for treatment and/or prevention of diabetes-associated and/or arterial poorly healing wounds |
| 05/03/2006 | EP1651237A2 Methods for treatment of dermatological conditions |
| 05/03/2006 | EP1651175A1 Use of spermine and/or spermidine against skin ageing in dietary, pharmaceutical or cosmetic compositions |
| 05/03/2006 | EP1560828B1 Imidazoquinoline derivatives as adenosine a3 receptor ligands |
| 05/03/2006 | EP1515955A4 Chemical process |
| 05/03/2006 | EP1513836B1 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
| 05/03/2006 | EP1505930A4 Drug-delivery endovascular stent and method for treating restenosis |
| 05/03/2006 | EP1419119B1 Water-insoluble, antimicrobial silicate glass and use thereof |
| 05/03/2006 | EP1353904B9 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands |
| 05/03/2006 | EP1289383B1 Primary composition containing a lipophilic bioactive compound |
| 05/03/2006 | EP1242400B1 Pyrrolidine derivatives as cyclic amp-specific phosphodiesterase inhibitors |
| 05/03/2006 | EP1232748B1 Use of substituted nitrobenzene derivatives for the treatment of diseases caused by bacteria, fungi and viruses |
| 05/03/2006 | EP1227805B1 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 05/03/2006 | EP1210065B1 Cationic liposome delivery of taxanes to angiogenic blood vessels |
| 05/03/2006 | EP1198557B1 Improved keratinocyte culture and uses thereof |
| 05/03/2006 | EP1126863B1 Vascular endothelial growth factor-like protein from orf virus nz10 binds and activates mammalian vegf receptor-2 |
| 05/03/2006 | EP0955995B1 Use of complexes for the preparation of compositions for the treatment of sensitive skin, preparation process and hypoallergenic compositions |
| 05/03/2006 | EP0937069B1 Piperazino derivatives as neurokinin antagonists |
| 05/03/2006 | EP0927217B1 Angiogenic inhibitory compounds |
| 05/03/2006 | CN1768065A Thienopyrimidine compound and use of the same |
| 05/03/2006 | CN1768054A Novel cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors |
| 05/03/2006 | CN1767839A Antiallergic composition |
| 05/03/2006 | CN1767765A Skin preparation composition for external use |
| 05/03/2006 | CN1765929A Fusion protein and nucleic acid containing peptide carrier and epidermal growth factor and its uses |
| 05/03/2006 | CN1765918A 17aª‡-D-high valent alkyneestradiol-3-ethyl ester and its synthesis and preparation method, pharmaceutical composition using the said compound as active ingredient |
| 05/03/2006 | CN1765417A Composition containing PVA-124 and its application |
| 05/03/2006 | CN1765416A Health caring plaster |
| 05/03/2006 | CN1765411A Wart removal liquid |
| 05/03/2006 | CN1765394A Beriberi treating medicine |
| 05/03/2006 | CN1765371A Spleen extracts, its preparation method and use |
| 05/03/2006 | CN1765369A Nano silver gel and its use |
| 05/03/2006 | CN1254487C Reformed monoclonal antibody for resisting immunoglobulin homoeotype |
| 05/03/2006 | CN1254478C Derivatives of monosaccharides as well adhesion inhibitors |
| 05/03/2006 | CN1254278C Medical ointment, film and tincture |
| 05/03/2006 | CN1254270C Water-soluble ginger-root extract |
| 05/03/2006 | CN1254258C Method for treating bacterial infection-type dermatopath and its preparing process |
| 05/03/2006 | CN1254257C Chinese medicinal bag for nourishing face and supplementing qi |
| 05/03/2006 | CN1254248C Tincture for curing freckle and melanotic nevus |
| 05/03/2006 | CN1254226C Face beautifying skin care compositions, its preparation method and uses |
| 05/03/2006 | CN1254225C Skin care cosmetic compositions containing phosphates and/or sulfates of branched alcohols and/or ethoxylates thereof |
| 05/02/2006 | US7038055 Sulfone derivatives and their use in the treatment of autoimmune diseases and allergies |
| 05/02/2006 | US7038051 Imidazonaphthyridines |
| 05/02/2006 | US7038048 Compositions for treatment of cell proliferation disorders |
| 05/02/2006 | US7038046 Triazine derivatives and their use as sunscreens |
| 05/02/2006 | US7038035 Nucleic acids codes polypeptides; mutants; insertion a vector; culturing; recovering |
| 05/02/2006 | US7038029 Vaccination |
| 05/02/2006 | US7037929 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| 05/02/2006 | US7037926 Anticarcinogenic, antiallergen, and antiinflammatory agents; autoimmuned diseases |
| 05/02/2006 | US7037925 for treating or preventing organ transplant rejection, lupus, multiple sclerosis, rheumatoid arthritis, psoriasis, Type I diabetes, asthma, rhinitis, atopic dermatitis, autoimmune disorders, Alzheimer's disease, leukemia |
| 05/02/2006 | US7037912 Enzyme inhibitor contains two or more ligand moieties comprising pyrimidinyl groups covalently linked together by linking groups; keratitis, diabetic retinopathy, angiogenesis, vision defects, ischemia, atherosclerosis,psoriasis, cancer, cirrhosis, diabetes, arthritis, autoimmune disease |
| 05/02/2006 | US7037899 Derivatives of 2-3-O- isopropylidene- alpha -L-xylo-2-hexulofuranosonic acid, useful for treating inflammatory and autoimmune diseases |
| 05/02/2006 | US7037896 HIV inhibiting peptide (VIRIP) and amidated, acetylated, sulfated, polyethylene glycol modified, phosphorylated and/or glycosylated derivatives |
| 05/02/2006 | US7037685 Nucleotide sequence coding polypeptide for use in the treatment and prevent of viral diseases, infections and tumors |
| 05/02/2006 | US7037666 Contacting latency-associated peptide- beta 1 (LAP- beta 1) or a functional variant thereof and integrin alpha v beta 3 or a functional variant thereof with test product under conditions that, in absence of test product, would permit interaction |
| 05/02/2006 | US7037665 Compositions comprising SNORF36 receptor compounds |
| 05/02/2006 | US7037489 Skin external agents and drugs |
| 05/02/2006 | CA2353342C Novel cationic associated polyurethanes and their use as thickening agent |
| 05/02/2006 | CA2334012C 2-aminopyridines containing fused ring substituents as nitric oxide synthase inhibitors |
| 05/02/2006 | CA2117939C Ceramides, process for their preparation and their uses in cosmetics and in dermopharmacy |
| 04/27/2006 | WO2006044379A2 Novel curcumin analogues and uses thereof |
| 04/27/2006 | WO2006043771A1 Composition comprising extract of anemarrhena asphodeloides and aralia elata, and use thereof |
| 04/27/2006 | WO2006043722A1 Chimeric (double) decoy |
| 04/27/2006 | WO2006043671A1 TRANSCRIPTIONAL FACTOR Nrf2 ACTIVATOR AND FOOD HAVING THE FUNCTION OF THE SAME IMPARTED THERETO |
| 04/27/2006 | WO2006043477A1 Nerve growth factor production inhibitor and external preparation for the skin, cosmetic, quasi drug, preventive and remedy for itching and remedy for atopic dermatitis containing the nerve growth factor production inhibitor |
| 04/27/2006 | WO2006042890A1 Therapeutic composition for the treatment of burns |
| 04/27/2006 | WO2006042626A1 Depilation agent or color-changing or shape-changing fiber treatment agents with active substances for stimulating the release of $g(b)-endorphin in keratinocytes |
| 04/27/2006 | WO2006042625A2 Compositions with inhibitors of the synthesis of prostaglandin and/or of leukotriene in conjunction with stimulators of the release of cutaneous neuromediators |
| 04/27/2006 | WO2006042370A1 Hair and nail compositions and methods |
| 04/27/2006 | WO2006021660A8 Use of at least one conjugated triene-containing fatty acid for preparing a medicine for treating inflammation |
| 04/27/2006 | US20060089406 Inhibitors of the fatty acid oxidation for the prophylaxis and/or the treatment of chronic and/or atopic skin diseases |
| 04/27/2006 | US20060089404 Ppar alpha selective compounds for the treatment of dyslipidemia and other lipid disorders |
| 04/27/2006 | US20060089401 Kinase inhibitors |
| 04/27/2006 | US20060089393 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors |
| 04/27/2006 | US20060089353 Indole derivative compounds and drugs containing the compounds as the active ingredient |